Overview
Ultromics EchoGo® provides clinically validated AI solutions for diagnosing complex cardiac diseases. By analyzing routine echocardiograms, EchoGo® aids in the detection of Heart Failure with preserved Ejection Fraction (HFpEF) and Cardiac Amyloidosis. The platform integrates seamlessly into existing clinical workflows, delivering automated reports within 20 minutes. EchoGo® processes cases using algorithms developed from extensive, annotated datasets and peer-reviewed publications. It assists healthcare professionals by improving diagnostic accuracy, supporting clinical decisions, and reducing the burden of undetected cardiac conditions. The technology has received FDA clearance and Breakthrough Device Designation.